Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths - Quiz - MDSpire

Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths

  • By

  • Davide Leardini

  • Giacomo Gambuti

  • Edoardo Muratore

  • Francesco Baccelli

  • Francesca Gottardi

  • Francesco Venturelli

  • Tamara Belotti

  • Arcangelo Prete

  • Marco Fabbrini

  • Patrizia Brigidi

  • Silvia Turroni

  • Riccardo Masetti

  • December 3, 2024

  • 0 min

Share

Original Source(s)

Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths

  • by Davide Leardini, Giacomo Gambuti, Edoardo Muratore, Francesco Baccelli, Francesca Gottardi, Francesco Venturelli, Tamara Belotti, Arcangelo Prete, Marco Fabbrini, Patrizia Brigidi, Silvia Turroni, Riccardo Masetti

  • December 3, 2024

Related Content

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.

Mass Spec Roundup: Protein Stress, Cannabis Chemistry and Sharks… 

From T cell dysfunction to shark vertebrae, mass spectrometry traces hidden chemistry across cells, crops, foods, and river systems 

  • May 6, 2026

  • 7 min
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study